What Reclast treats.
- Postmenopausal osteoporosis
- Osteoporosis in men
- Steroid-induced osteoporosis
- Paget’s disease of bone
The mechanism.
Reclast (zoledronic acid) is a bisphosphonate that binds to bone and slows the activity of osteoclasts — cells that break down bone. By reducing bone breakdown, Reclast increases bone density and significantly reduces fracture risk over time.
Your Reclast infusion experience.
Reclast is a once-yearly infusion lasting about 15 minutes. Adequate hydration before and after is important. Some patients experience flu-like symptoms (acetaminophen helps) within 1 to 3 days of the first infusion — this typically does not recur with subsequent yearly doses.
Insurance & out-of-pocket cost.
Reclast is covered by most commercial insurance and Medicare Part B when prescribed by your physician for an FDA-approved indication. We verify your benefits before your first infusion and handle prior authorization on your behalf. Most commercially insured patients pay only their standard specialty copay — typically $20–$100 per visit. Manufacturer copay assistance programs may further reduce your cost.